Oncorus is based in Cambridge, MA. It has raised $141M in total funding. Latest round: Series B.
Oncorus funding overview
Oncorus is based in Cambridge, MA. Oncorus has raised $141M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in August 2019. The round record for Oncorus runs through 2019; nothing later has been disclosed. Investors on record include Arkin Bio Ventures, Astellas Venture Management, Celgene Corporation, Cowen Healthcare Investments, Deerfield Management Company, L.P., IMM Investment and 6 others. 12 distinct backers are named across the disclosed rounds.
Oncorus has raised $141M in total disclosed funding across the rounds on record.
Who has invested in Oncorus?
Arkin Bio Ventures, Astellas Venture Management, Celgene Corporation, Cowen Healthcare Investments, Deerfield Management Company, L.P., IMM Investment are named among the investors backing Oncorus.
What was the latest Oncorus funding round?
The most recent disclosed round is a Series B, announced in August 2019.
Where is Oncorus based?
Oncorus is based in Cambridge, MA.
When did Oncorus last raise?
The last disclosed Oncorus round closed in August 2019 at Series B.
Totals shown for Oncorus aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
